BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint
BIOLIFE SOLUTIONS (NASDAQ: BLFS) Delayed: 19.86 -0.26 (1.29%)
Previous Close $20.12    52 Week High $3.58 
Open $19.71    52 Week Low $1.43 
Day High $19.89    P/E N/A 
Day Low $19.23    EPS $0.00 
Volume 469,778       

Intelligroup, Inc. (NASDAQ: TIG) Delayed: 6.16 --0 (-0%)
Previous Close $6.16    52 Week High $0.09 
Open $0.03    52 Week Low $0.03 
Day High $6.16    P/E N/A 
Day Low $6.16    EPS $-0.16 
Volume 1,500